How to Take Vitamin K2: Dosage, Timing, Duration

Vitamin K2 is an ordinary dietary supplement, and for it we can give practical guidelines: how much to take, when, and for how long. But the difference between MK-7 and MK-4 doses is a hundredfold, and absorption depends heavily on food. Our editorial team gathered data from clinical studies and turned it into clear rules.

Before you begin: for whom and why

The first question is not «how much» but «whether it is needed». Most people with a varied diet get the official vitamin K norms (90–120 mcg per day per the US Institute of Medicine and about 70 mcg per EFSA) from food, mainly in the form of K1 from green vegetables.

A K2 supplement makes the most sense for people at risk of osteoporosis, postmenopausal women, people with a diet poor in vegetables and fermented foods, and those who take high doses of vitamin D over a long period. For young, healthy athletes with a normal diet it is not mandatory.

The second question is safety. People taking warfarin or other vitamin K antagonists must not start taking K2 on their own: even small doses change the effect of the medication. It is also worth consulting a doctor if you have chronic liver, kidney, or blood conditions.

The third is the goal. It determines which form and dose it is sensible to choose and how long to take it. Bone effects in studies appear no earlier than after a year, so short «courses» of a month for this purpose are pointless.

Dosage: MK-7 and MK-4

MK-7.The most studied dose in long-term randomized trials is 180 mcg per day: this is precisely what Knapen et al. used in three-year studies of bone density (2013) and arterial stiffness (2015). In a study by Theuwissen et al. (2012) even smaller doses of MK-7 improved vitamin K status in extrahepatic tissues, assessed by the level of uncarboxylated MGP.

On the market, supplements with a dose of 45–200 mcg of MK-7 per capsule are common. For preventive purposes in healthy adults, our editorial team considers a range of roughly 90–180 mcg per day to be a sensible benchmark, that is, within the doses studied in clinical trials. Higher doses have no proven advantages.

MK-4.This form has a short half-life and, in microgram doses, poorly raises blood levels: a study by Sato et al. (2012) showed that after taking 420 mcg of MK-4 its serum level barely rose, whereas MK-7 at the same dose was well detected. In Japan MK-4 is used to treat osteoporosis at a dose of 45 mg per day divided into three intakes — this is a prescription drug, not a supplement.

Children and adolescents do not need K2 supplements without a pediatrician’s recommendation, and for pregnant and breastfeeding women the dose is determined by a doctor. For older people with osteoporosis the decision on form and dose should also be made by a doctor — especially if MK-4 in medicinal doses is being considered.

Timing and absorption

Vitamin K2 is fat-soluble, and its absorption depends on bile and pancreatic enzymes. Taking it on an empty stomach or with a low-fat breakfast (coffee with toast) reduces absorption. The best moment is during a main meal that contains fats: lunch or dinner with oil, fish, eggs, nuts.

The half-life of MK-7 is about three days (Schurgers et al., 2007), so the specific hour of intake is not of great importance. Regularity matters more: daily intake with food ensures a stable level that gradually reaches a plateau over several days.

If you take several fat-soluble supplements (vitamins D, E, A, omega-3), it is convenient to take them together during one meal. Orlistat, bile-acid-binding drugs, and high-fiber supplements can reduce the absorption of fat-soluble vitamins, so they should be spaced apart in time.

Missing one dose of MK-7 is not a problem: thanks to the long circulation, the level declines slowly. There is no need to double the dose the next day.

Duration and assessing the effect

Biochemical changes, for example a decrease in the proportion of uncarboxylated osteocalcin or MGP, appeared in studies after just a few weeks of taking MK-7. However, these are laboratory markers, not a clinical outcome.

The effect on bone mineral density and arterial stiffness in the Knapen et al. studies was assessed after two to three years. So if the goal is bone health, it makes sense to take K2 over the long term, as part of an ongoing strategy, rather than in courses. No harm from long-term use was found in the studies.

It is difficult to assess the effect in everyday practice: special markers of vitamin K status are rarely done in ordinary laboratories. For people with osteopenia or osteoporosis, a doctor monitors densitometry (DXA) at set intervals.

Short courses «for the joints» or «for energy» lasting 1–2 months have no scientific basis. If you do not see a specific goal for long-term use, perhaps you do not need the supplement.

Combining with vitamin D, calcium, and medications

The popular D3 + K2 pair has a logical rationale: vitamin D increases the synthesis of osteocalcin and MGP, and vitamin K activates them. However, there are few studies that directly prove the combination is better than each vitamin separately for hard endpoints. Combined products are convenient, but pay attention to the vitamin D dose.

Calcium from supplements makes sense only when the diet does not meet the norm. The claim that K2 «directs calcium into the bones rather than the blood vessels» is a simplification of biochemical data, not a clinically proven fact.

• Vitamin K antagonists (warfarin):K2 only on a doctor’s decision and with INR monitoring.
• Broad-spectrum antibiotics (long-term):can reduce vitamin K status; discuss with a doctor.
• Orlistat, bile acid sequestrants:space out the timing.
• Direct oral anticoagulants:no direct interaction described, but consultation is needed.

People who take several supplements should make a simple list of all products with the doses of vitamins D and K indicated. Such a list will help a doctor quickly assess total intake and avoid duplication when the same vitamin is contained in a multivitamin, a joint complex, and a separate capsule.

A practical algorithm for a healthy adult without contraindications: MK-7 at a dose studied in trials, daily with a meal containing fats, long-term use with a clear goal, periodic review of the need together with a doctor.

Editorial conclusions

For MK-7 the benchmark is the doses studied in clinical trials, in particular 180 mcg per day in three-year studies. Higher doses have no proven advantages.

Take K2 with a meal containing fats; the time of day is not critical thanks to the long circulation of MK-7. Regularity matters more than exact timing.

Effects on bones and blood vessels develop over years, so only long-term use makes sense with well-founded indications.

We also recommend reading our articles «Vitamin K2: Available Forms and Which to Choose», «Side Effects of Vitamin K2», and «Who Should Not Take Vitamin K2».

References

1. Schurgers LJ, Teunissen KJ, Hamulyák K, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279–3283.
2. Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 2012;11:93.
3. Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499–2507.
4. Knapen MH, Braam LA, Drummen NE, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thromb Haemost. 2015;113(5):1135–1144.
5. Theuwissen E, Cranenburg EC, Knapen MH, et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr. 2012;108(9):1652–1657.
6. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies Press; 2001.
7. EFSA Panel on Dietetic Products, Nutrition and Allergies. Dietary reference values for vitamin K. EFSA Journal. 2017;15(5):4780.